Gurney, H <br/><br/>
Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Jul 2007 
 - 33-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1038/sj.clpt.6100201  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Benzamides<br/>Cohort Studies<br/>Cytochrome P-450 CYP3A<br/>Cytochrome P-450 Enzyme System--genetics<br/>Drug Monitoring<br/>Female<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Genotype<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Organic Anion Transporters--antagonists & inhibitors<br/>Phenotype<br/>Piperazines--administration & dosage<br/>Polymorphism, Single Nucleotide<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrimidines--administration & dosage